BTS
HQL

BB&T Securities’s abrdn Life Sciences Investors HQL Stock Holding History

BB&T Securities’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12,456
Closed -$188K – 1625
2018
Q4 		$188K Sell
12,456
-300
-2% -$5.28K ﹤0.01% 1371
2018
Q3 		$260K Buy
12,756
+61
+0.5% +$1.21K ﹤0.01% 1381
2018
Q2 		$238K Buy
12,695
+2,000
+19% +$37.6K ﹤0.01% 1383
2018
Q1 		$205K Sell
10,695
-1,000
-9% -$20K ﹤0.01% 1400
2017
Q4 		$229K Sell
11,695
-516
-4% -$10.3K ﹤0.01% 1296
2017
Q3 		$262K Sell
12,211
-1,750
-13% -$37.2K ﹤0.01% 1206
2017
Q2 		$291K Buy
13,961
+161
+1% +$3.25K ﹤0.01% 1164
2017
Q1 		$267K Sell
13,800
-11,850
-46% -$220K ﹤0.01% 1088
2016
Q4 		$480K Hold
25,650
– – 0.01% 845
2016
Q3 		$480K Buy
25,650
+4,000
+18% +$75.4K 0.01% 846
2016
Q2 		$372K Buy
+21,650
New +$400K 0.01% 904

Other funds holding HQL

NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

BB&T Securities's HQL Position: Q1 2019 in Review

BB&T Securities sold out of abrdn Life Sciences Investors (HQL) in Q1 2019, closing a stake of 12,456 shares — an estimated $188K sold.

BB&T Securities first reported a position in HQL in Q2 2016 and held it in 11 quarters. The position peaked at $480K in Q4 2016. 56 funds tracked by Wall St. Rank hold HQL as of Q1 2019.

  • BB&T Securities reported no remaining abrdn Life Sciences Investors position as of Q1 2019 after selling out during the quarter.
  • BB&T Securities sold 12,456 abrdn Life Sciences Investors shares in Q1 2019, an estimated $188K.
  • BB&T Securities first reported a position in abrdn Life Sciences Investors in Q2 2016 and held it in 11 quarters.
  • BB&T Securities's abrdn Life Sciences Investors position peaked at $480K in Q4 2016.
  • 56 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2019.

Based on BB&T Securities's 13F filing for Q1 2019, filed 14 May 2019.